Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tegafur-gimeracil-oteracil potassium
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-25 of 97 for your search:
Start Over
Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer
Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: BEST T-01, NCT01849380
A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: OXALI_L_06366, NCT01997957
Perioperative Chemotherapy for Potentially Resectable Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: TOTTG030103, NCT01516944
Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: ESCC001, NCT01704690
Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: NCRT-GEJ, NCT02193594
The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer
Phase: Phase III, Phase II
Type: Health services research, Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2010006, NCT02423278
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 75
Sponsor: Other
Protocol IDs: JCOG0501, C000000279, NCT00252161
Trial of S-1 Plus Cisplatin in Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2005L02859, NCT01198392
Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: 4-2009-0708, NCT01283217
Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: DOCET_R_05153, EFC13833, NCT01515748
SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 75
Sponsor: Other
Protocol IDs: LCHEN-PLAGH, NCT01583361
A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: Fudan BR2012-09 CBCSG011, NCT01655992
S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AMC-ONCGI-1202, NCT01671449
Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial
Phase: Phase III
Type: Treatment
Status: Active
Age: Over 19
Sponsor: Other
Protocol IDs: 2012-06-061, NCT01761461
Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: SYSUCCGPS, ZHOUZHIWEI, NCT01795027
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Diffuse Gastric Adenocarcinoma Patients
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SOX-DGCA, NCT01824459
S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SALTO, NCT01918852
Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: 20140113/16-2014-9/021, NCT02114359
Intraperitoneal Chemotherapy and Systemic Chemotherapy Versus Systemic Chemotherapy After Curative Resection of Serosa-positive Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 19 to 70
Sponsor: Other
Protocol IDs: EPIC-GC, KNUMCGCC-001, NCT02205008
Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: CH-GI-064, NCT02319187
Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 74
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10056040, NCT02322593
Comparison of SEEOX and SOX Regimens in Unresectable Gastric Cancer Patients
Phase: Phase III
Type: Treatment
Status: Active
Age: 30 to 70
Sponsor: Other
Protocol IDs: 20140621, 08Z28, NCT02338518
SP Intravenous Chemotherapy Versus SP by HIPEC in Stage ? Patients After D2 Gastrectomy
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: TDCCC005, NCT02396498
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NCCCTS-08-333, NCT00874328
Start Over